Regardless of the underlying cause, most CRC cells exhibit activation of pathways driving survival, proliferation, or immune response, including WNT/β-Catenin, nuclear factor-κB; NF-κB, and signal transducer and activator of transcription 3 (STAT3) (14–16). The gene discussed is STAT3; the disease is colorectal carcinoma.